These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8502581)

  • 1. A method to increase the cumulative cleavage efficiency of ribozymes: thermal cycling.
    Dropulić B; Lin NH; Jeang KT
    Nucleic Acids Res; 1993 May; 21(9):2273-4. PubMed ID: 8502581
    [No Abstract]   [Full Text] [Related]  

  • 2. Cleavage of the highly conserved hairpin-loop region of HIV-1 by synthetic ribozymes.
    Shimayama T; Nishikawa S; Taira K
    Nucleic Acids Symp Ser; 1993; (29):177-8. PubMed ID: 8247758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric DNA-RNA hammerhead ribozymes have enhanced in vitro catalytic efficiency and increased stability in vivo.
    Taylor NR; Kaplan BE; Swiderski P; Li H; Rossi JJ
    Nucleic Acids Res; 1992 Sep; 20(17):4559-65. PubMed ID: 1408757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multifunctional expression vector for an anti-HIV-1 ribozyme that produces a 5'- and 3'-trimmed trans-acting ribozyme, targeted against HIV-1 RNA, and cis-acting ribozymes that are designed to bind to and thereby sequester trans-activator proteins such as Tat and Rev.
    Yuyama N; Ohkawa J; Koguma T; Shirai M; Taira K
    Nucleic Acids Res; 1994 Nov; 22(23):5060-7. PubMed ID: 7800500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of HIV-1 gp41 expression with hammerhead ribozymes.
    Fedoruk-Wyszomirska A; Szymański M; Głodowicz P; Gabryelska M; Wyszko E; Estrin WJ; Barciszewski J
    Biochem J; 2015 Oct; 471(1):53-66. PubMed ID: 26209679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and mode of action of hammerhead and hairpin ribozymes against various HIV-1 target sites.
    Hotchkiss G; Maijgren-Steffensson C; Ahrlund-Richter L
    Mol Ther; 2004 Jul; 10(1):172-80. PubMed ID: 15233952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific cleavage of two target sequences of the tobacco mosaic virus RNA by a di-component ribozyme.
    Li J; Jin H; Zhang Q; Song R; Xu Z
    Chin J Biotechnol; 1995; 11(1):27-35. PubMed ID: 7548768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of structure in a long target RNA on ribozyme cleavage efficiency.
    Campbell TB; McDonald CK; Hagen M
    Nucleic Acids Res; 1997 Dec; 25(24):4985-93. PubMed ID: 9396806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simple method to produce RNA size markers using cis ribozymes.
    Borneman J; Altschuler M
    Biotechniques; 1995 Mar; 18(3):405-6. PubMed ID: 7540017
    [No Abstract]   [Full Text] [Related]  

  • 10. Multiple site-specific cleavage of HIV RNA by transcribed ribozymes from shotgun-type trimming plasmid.
    Ohkawa J; Yuyama N; Takebe Y; Nisikawa S; Homann M; Sczakiel G; Taira K
    Nucleic Acids Symp Ser; 1993; (29):121-2. PubMed ID: 8247732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target sequence-specific inhibition of HIV-1 replication by ribozymes directed to tat RNA.
    Sun LQ; Wang L; Gerlach WL; Symonds G
    Nucleic Acids Res; 1995 Aug; 23(15):2909-13. PubMed ID: 7544887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture.
    Bramlage B; Luzi E; Eckstein F
    Nucleic Acids Res; 2000 Nov; 28(21):4059-67. PubMed ID: 11058100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of HIV-1 replication by ribozymes that show poor activity in vitro.
    Crisell P; Thompson S; James W
    Nucleic Acids Res; 1993 Nov; 21(22):5251-5. PubMed ID: 8255782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activities of HIV-RNA targeted ribozymes transcribed from a 'shot-gun' type ribozyme-trimming plasmid.
    Ohkawa J; Yuyama N; Taira K
    Nucleic Acids Symp Ser; 1992; (27):15-6. PubMed ID: 1289797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the in vitro activity of DNA-armed and all-RNA hammerhead ribozymes.
    Hendry P; McCall MJ
    Nucleic Acids Res; 1995 Oct; 23(19):3928-36. PubMed ID: 7479038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multitarget-ribozyme directed to cleave at up to nine highly conserved HIV-1 env RNA regions inhibits HIV-1 replication--potential effectiveness against most presently sequenced HIV-1 isolates.
    Chen CJ; Banerjea AC; Harmison GG; Haglund K; Schubert M
    Nucleic Acids Res; 1992 Sep; 20(17):4581-9. PubMed ID: 1408760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and anti-HIV-1 activity of ribozymes that cleave HIV-1 LTR.
    Koizumi M; Ozawa Y; Yagi R; Nishigaki T; Kaneko M; Oka S; Kimura S; Iwamoto A; Komatsu Y; Ohtsuka E
    Nucleic Acids Symp Ser; 1995; (34):125-6. PubMed ID: 8841584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclease-resistant chimeric ribozymes containing deoxyribonucleotides and phosphorothioate linkages.
    Shimayama T; Nishikawa F; Nishikawa S; Taira K
    Nucleic Acids Res; 1993 Jun; 21(11):2605-11. PubMed ID: 8332458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A three-nucleotide helix I is sufficient for full activity of a hammerhead ribozyme: advantages of an asymmetric design.
    Tabler M; Homann M; Tzortzakaki S; Sczakiel G
    Nucleic Acids Res; 1994 Sep; 22(19):3958-65. PubMed ID: 7937118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of hammerhead ribozymes by retroviral vectors to inhibit HIV-1 replication: comparison of RNA levels and viral inhibition.
    Zhou C; Bahner I; Rossi JJ; Kohn DB
    Antisense Nucleic Acid Drug Dev; 1996; 6(1):17-24. PubMed ID: 8783792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.